News & Events CTI Clinical Trial and Consulting Services Announces Dr. William Irish to Participate in “Consensus Conference on Transplant Program Quality and Surveillance”

CTI Clinical Trial and Consulting Services Announces Dr. William Irish to Participate in “Consensus Conference on Transplant Program Quality and Surveillance”

February 13, 2012

William Irish, PhD has been invited to participate in the “Consensus Conference on Transplant Program Quality and Surveillance” sponsored jointly by the Scientific Registry of Transplant Recipients (SRTR) and the Organ Procurement and Transplantation Network (OPTN). The program will be held February 13-15, 2012 in Arlington, Virginia.

Dr. Irish, Vice President of Health Outcomes and Biostatistics at CTI Clinical Trial and Consulting Services (CTI), is an internationally recognized expert in the areas of study design and analysis. He has been a leading resource in transplantation for more than twenty years, beginning as a faculty member at the University of Pittsburgh and continuing throughout his career in various biotechnology and pharmaceutical areas.

According to conference information, “Organ transplant programs in the U.S. must submit data to the OPTN. These data are used by SRTR to calculate each transplant program’s observed and expected outcomes, which are then reported regularly to the OPTN Membership and Professional Standards Committee (MPSC), the Centers for Medicare and Medicaid Services (CMS) and the general public. When a transplant program fails to achieve expected outcomes, it becomes the target of further scrutiny by both the MPSC and CMS. In addition, private insurance providers may use these same data to determine where their patients are referred for transplantation. The consensus conference was designed to identify and discuss strengths and weaknesses of this process. The goals of the conference are to identify areas where there is agreement and to make recommendations for improving the process. A summary of the conference will be published as a manuscript.”

“We are very pleased that Dr. Irish has been invited to participate in this important conference and look forward to the white paper summary” according to Kevin Schwarz, CTI SVP, Clinical Trial Development.

Subscribe to our mailing list

* indicates required